Weight-suppressant drugs, like GLP-1 agonists, have helped millions achieve weight loss. However, many individuals regain the lost weight once they stop taking the medication, raising questions about long-term health. At Trim, we see this as a learning opportunity to emphasise the importance of viewing weight management as a lifelong commitment. These drugs, including popular ones like Ozempic and Wegovy, offer significant health benefits, but they are not a “quick fix.” Just like managing chronic conditions, a long-term strategy is key for lasting success.

GLP-1 agonists, which mimic natural gut hormones that regulate appetite, have shown impressive results—such as 15-20% weight loss in major trials. Additionally, they have proven to reduce risks like heart attacks and strokes. However, studies show that many patients quickly regain lost weight after discontinuing the drugs. This weight rebound is often due to the brain’s return to its natural state of appetite regulation. The solution? Maintaining treatment and supporting patients in staying the course.

At Trim, we aim to help clients understand that these treatments are part of a broader lifestyle change. Weight management is not a one-time solution, but rather a journey that involves continuous learning, support, and commitment. As we continue to learn about the complexities of obesity, we believe that personalised care—combining medications, diet, exercise, and education—will be the future of long-term success.

With the growing availability of generic alternatives and improved dosing strategies, weight-suppressant drugs are becoming more accessible for sustained use. At Trim, we believe in long-term health solutions, and we’re here to guide you every step of the way.